According to a study led by a Belgian scientist at the University of Oxford, the shingles vaccine, Shingrix, could reduce the risk of dementia as well as cardiovascular diseases by potentially inhibiting infection from the herpes zoster virus, which could have significant implications for the health of the elderly. (translated)


